Nasal immune cell spray passes first safety check in small study
NCT ID NCT06699758
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 23 times
Summary
This early-stage study tested whether a nasal spray containing immune cells from a male donor is safe for healthy women aged 18 to 55. Nine participants received the spray and were monitored for side effects over a week. The goal was only to check safety and tolerability, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TO ASSESS THE SAFETY AND TOLERABILITY OF INTRANASAL ADMINISTRATION OF A MALE DONOR MEMORY T LYMPHOCYTE SOLUTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitario La Paz
Madrid, Madrid, 28046, Spain
Conditions
Explore the condition pages connected to this study.